SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-060966
Filing Date
2021-05-04
Accepted
2021-05-04 16:06:55
Documents
47
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111660d1_10q.htm 10-Q 244113
2 EXHIBIT 31.1 tm2111660d1_ex31-1.htm EX-31.1 11855
3 EXHIBIT 32.1 tm2111660d1_ex32-1.htm EX-32.1 5571
  Complete submission text file 0001104659-21-060966.txt   1703126

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT enzn-20210331.xml EX-101.INS 217528
5 XBRL TAXONOMY EXTENSION SCHEMA enzn-20210331.xsd EX-101.SCH 28386
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20210331_cal.xml EX-101.CAL 15591
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20210331_def.xml EX-101.DEF 71460
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20210331_lab.xml EX-101.LAB 166630
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20210331_pre.xml EX-101.PRE 146755
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 21888435
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences